Skip to main content
. 2017 Jul 18;10:3545–3556. doi: 10.2147/OTT.S134162

Table 1.

Relationship of serum DKK1 autoantibodies with clinicopathological characteristics of 206 NSCLC patients

Group N (%) Pep A
P-value Pep B
P-value Pep C
P-value Pep D
P-value
Median (IQR) Median (IQR) Median (IQR) Median (IQR)
Age, years 0.267 0.064 0.142 0.715
 >60 92 (45) 0.49 (0.35–0.74) 0.55 (0.43–0.94) 0.52 (0.36–0.72) 0.52 (0.39–0.92)
 ≤60 114 (55) 0.45 (0.32–0.67) 0.51 (0.35–0.78) 0.46 (0.31–0.64) 0.54 (0.38–0.84)
Gender 0.038 0.034 0.003 0.105
 Male 144 (70) 0.50 (0.33–0.78) 0.57 (0.40–0.89) 0.52 (0.35–0.79) 0.56 (0.40–0.90)
 Female 62 (30) 0.45 (0.28–0.59) 0.51 (0.35–0.69) 0.41 (0.29–0.57) 0.48 (0.34–0.83)
Smoking history 0.244 0.009 0.158 0.625
 Yes 125 (61) 0.49 (0.33–0.75) 0.60 (0.42–0.89) 0.50 (0.34–0.72) 0.54 (0.39–0.85)
 No 81 (39) 0.46 (0.29–0.60) 0.47 (0.35–0.69) 0.44 (0.30–0.68) 0.52 (0.38–0.85)
Histological subtype 0.072 0.053 0.029 0.005
 A 119 (58) 0.45 (0.31–0.59) 0.51 (0.37–0.75) 0.45 (0.32–0.62) 0.49 (0.34–0.80)
 S 87 (42) 0.51 (0.35–0.90) 0.65 (0.39–0.72) 0.54 (0.34–0.96) 0.57 (0.42–1.27)
TNM stage 0.209 0.001 0.001 0.002
 I 32 (16) 0.43 (0.30–0.81) 0.53 (0.35–0.85) 0.51 (0.42–0.83) 0.69 (0.45–0.92)
 II 25 (12) 0.41 (0.35–0.53) 0.57 (0.42–0.77) 0.43 (0.28–0.53) 0.51 (0.30–0.79)
 III 84 (40) 0.51 (0.37–0.76) 0.60 (0.43–1.04) 0.56 (0.40–0.78) 0.59 (0.44–1.06)
 IV 65 (32) 0.45 (0.29–0.59) 0.46 (0.33–0.69) 0.36 (0.30–0.68) 0.45 (0.30–0.59)
Lymph node 0.822 0.792 0.789 0.356
 Yes 143 (69) 0.48 (0.32–0.63) 0.55 (0.37–0.83) 0.47 (0.32–0.68) 0.51 (0.38–0.85)
 No 61 (30) 0.46 (0.33–0.83) 0.53 (0.37–0.88) 0.48 (0.34–0.68) 0.57 (0.40–0.94)
 Unknown 2
Distant metastases 0.126 0.007 0.007 0.001
 Yes 65 (32) 0.45 (0.29–0.59) 0.46 (0.33–0.69) 0.36 (0.29–0.57) 0.45 (0.30–0.59)
 No 141 (68) 0.49 (0.35–0.76) 0.59 (0.40–0.90) 0.52 (0.38–0.76) 0.59 (0.42–0.95)

Abbreviations: A, adenocarcinoma; DKK1, dickkopf-1; IQR, inter-quartile range; NSCLC, non-small cell lung cancer; S, squamous cell carcinoma; TNM, tumor-node-metastasis.